Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00324727 Information provided by National Cancer Institute (NCI)

First Received: May 10, 2006 Last Updated: November 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given